Skip to main content

Table 3 The impact of sociodemographic factors and diabetic disease-related determinants on adherence to treatment (N = 284)

From: Translation, cultural adaptation and validation of the General Medication Adherence Scale (GMAS) in moroccan patients with type-2 diabetes

 

≤ 26

≥ 27

P

Cramer’s V

N

%

N

%

Place of residence

13

 

271

 

0.966

0.002

Rural

12

92.30

251

92.61

  

Urban

1

07.70

20

7.39

  

Sex

13

 

271

 

0.604

0.031

Male

7

53.84

126

46.49

  

Female

6

46.16

145

53.51

  

Marital status

13

 

271

 

0.604

0.031

Single

2

15.38

49

18.08

  

Married

8

61.53

178

65.68

  

Widow(er)

3

23.07

36

13.28

  

Divorced

0

00.00

8

2.95

  

Level of education

13

 

271

 

0.444

0.115

No education

13

100

210

77.49

  

Primary

0

00.00

35

12.91

  

College

0

00.00

16

5.90

  

High School

0

00.00

3

1.70

  

University

0

00.00

7

2.58

  

Employment status

13

 

271

 

0.533

0.067

Unemployed

13

100

247

91.14

  

Retired

0

00.00

12

4.42

  

Assets

0

00.00

12

4.42

  

Social security coverage

13

 

271

 

0.890

0.047

Insured

12

92.30

232

85.60

  

Without insurance

1

07.69

39

14.39

  

Type of health insurance

13

 

271

 

0.433

0.098

CNOPS

0

00.00

30

11.07

  

CNSS

0

00.00

14

5.10

  

RAMED

13

00.00

227

83.76

  

Treatment

13

 

271

 

0.049*

0.163

One OAD

5

38.46

110

40.59

  

OAD + Insulin

3

23.07

15

5.53

  

Two or more OADs

1

07.69

66

24.35

  

Insulin alone

4

30.76

80

29.52

  

Name of OAD taken

13

 

271

 

0.202

0.160

Glimepiride 2 mg

0

00.00

18

6.64

  

Gliclazide 60 mg

0

00.00

42

15.49

  

Metformin 1000 mg

10

76.92

148

54.61

  

Gliclazide + Metformin

0

00.00

33

12.17

  

Glimepiride + Metformin

3

23.07

30

11.07

  

Associations

13

 

271

 

0.090

0.151

Monotherapy

6

46.15

179

66.05

  

Dual therapy

2

15.38

83

30.62

  

Triple therapy and more

2

15.38

9

3.32

  

Associated diseases

13

 

271

 

0.003*

0.266

AHT

3

23.07

121

44.64

  

Dyslipidemia

4

30.76

113

41.69

  

Other pathologies

4

30.76

25

9.22

  

AHT + Dyslipidemia

1

07.69

4

1.47

  

AHT + Others

1

07.69

1

0.36

  

AHT + Dyslipidemia + Others

0

00.00

7

2.58

  

Duration of disease

13

 

271

 

0.998

0.043

Less than a year

1

07.69

16

5.90

  

1 to 5 years

5

38.46

88

32.47

  

6 to 10 years

4

30.76

10

38.00

  

11 to 15 years

1

07.69

25

9.22

  

16 to 20 years

1

07.69

22

8.11

  

21 years and more

1

07.69

17

6.27

  

Self-monitoring of blood glucose

13

 

271

 

0.102

0.127

Yes

4

30.76

167

61.62

  

No

9

69.23

117

43.17

  

Information about diabetes

13

 

271

 

0.127

0.091

Informed patients

5

38.46

162

59.77

  

Uninformed patients

8

61.5

109

40.22

  
  1. *Significant p value < 0.05
  2. AHT = Hypertension
  3. OAD = oral antidiabetic drug